Key Considerations in Managing Hypertension Risk with BTKis in CLL

Opinion
Video

Amber Koehler, PA-C, provides expert perspective on addressing hypertension risk in CLL patients undergoing treatment with BTK inhibitors.

CN_ATP_CLL_MAYO_Seg10
Video Player is loading.
Current Time 0:00
Duration 3:28
Loaded: 4.73%
Stream Type LIVE
Remaining Time 3:28
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
    Related Content